Nucleotide substitution: G2861A. Amino acid replacement: S?G. The nucleotide substitution is at the putative exon 3/intron 3 junction, results in an S to G amino acid change and is also predicted to reduce splicing efficiency of intron 3, introducing an in-frame translational stop codon in the unspliced intron.
viable (with cicfet-E11)
visible (with cicfet-E11)
Number of mitotic cells per midgut is significantly increased in cicfet-T6/cicfet-E11 transheterozygous adults.
Approximately 32.8% of cicfet-U6/cicfet-T6 females exhibit a weak-moderate eggshell phenotype. The dorsal midline is expanded and the appendages are broader and positioned laterally and exhibit a ventral collar of ectopic appendage-like material. The dorsalmost region remains free of appendage material.
Approximately 44.6% of cicfet-U6/cicfet-T6 females exhibit a moderate eggshell phenotype. The dorsal midline is expanded and the appendages are broader and positioned laterally and exhibit a thick ventral collar of ectopic appendage-like material. The dorsalmost region remains free of appendage material.
Approximately 20.9% of cicfet-U6/cicfet-T6 exhibit a moderate-severe eggshell phenotype. The dorsal midline is expanded and the appendages are broader and positioned laterally and exhibit a pronounced ventral collar of ectopic appendage-like material. The dorsalmost region remains free of appendage material.
Approximately 1.7% of cicfet-U6/cicfet-T6 exhibit a severe eggshell phenotype. The dorsal midline is expanded and the appendages are broader and positioned laterally and exhibit a pronounced ventral collar of ectopic appendage-like material, along with small anterior projections.
cicfet-T6/cicfet-E11 females lay eggs with a dorsalised eggshell and embryo.
cicfet-U6/cicfet-T6 has dorsal appendage phenotype, suppressible by mirr6D1
cicfet-U6/cicfet-T6 has dorsal appendage phenotype, non-suppressible by grk3/grk2B6
cicfet-U6/cicfet-T6 has dorsal appendage phenotype, non-suppressible by rho6
Egfrt1, cicfet-T6/cicfet-E11 has embryonic/first instar larval cuticle phenotype
Egfrt1, cicfet-T6/cicfet-E11 has egg chorion phenotype
Approximately 0.5% of cicfet-T6/mirr6D1 cicfet-U6 females exhibit a weak eggshell phenotype. The dorsal midline is expanded and the appendages are broader and positioned laterally with a trace of ventral collar material. Approximately 42.6% of cicfet-U6/mirr6D1 cicfet-T6 females exhibit a moderate eggshell phenotype. The dorsal midline is expanded and the appendages are broader and positioned laterally and exhibit a ventral collar of ectopic appendage-like material. The dorsalmost region remains free of appendage material. Approximately 42.1% of cicfet-U6/mirr6D1 cicfet-T6 females exhibit a moderate-severe eggshell phenotype. The dorsal midline is expanded and the appendages are broader and positioned laterally and exhibit a thick ventral collar of ectopic appendage-like material. The dorsalmost region remains free of appendage material. None of the cicfet-U6/mirr6D1 cicfet-T6 females exhibit a severe eggshell phenotype (compared to 1.7% in the heterozygote). There is an increase in the weak phenotype, and a decrease in the severe phenotype compared to the cicfet-T6/cicfet-U6 mutant, indicating that mirr6D1 suppresses the cicfet-T6/cicfet-U6 phenotype.
Stage 12 grk3/grk2B6 ; cicfet-U6/cicfet-T6 double mutant egg chambers lack dorsal appendages (characteristic of loss of grk), but retain a pronounced collar of appendage material, indicating that loss of grk cannot suppress the cic phenotype.
rho6 mutant clones have no effect on the ectopic appendage-producing fates in cicfet-U6/cicfet-T6 mutant egg chambers, indicating that loss of rho function cannot suppress the cic phenotype.
Egfrt1/Egfrt1 ; cicfet-T6/cicfet-E11 females lay eggs with a dorsalised embryo (like cicfet-T6/cicfet-E11 single mutant females) and an eggshell that shows a combination of cic and Egfr mutant phenotypes; the dorsal appendages are broadened (as in cic mutants) but are positioned closer to the dorsal midline (as in Egfr mutants).
Selected as: a mutant that shows extra wing veins or blisters over cicfet-E11.